ABSTRACT Background: Diet may be associated with the development of type 2 diabetes through its effects on low-grade inflammation. Objectives: We investigated whether an adapted dietary inflammatory index (ADII) is associated with a summary score for low-grade inflammation and markers of glucose metabolism. In addition, we investigated the mediating role of inflammation in the association between ADII and markers of glucose metabolism. Design: We performed cross-sectional analyses of 2 Dutch cohort studies (n= 1024). An ADII was obtained by multiplying standardized energy-adjusted intakes of dietary components by literaturebased dietary inflammatory weights that reflected the inflammatory potential of components. Subsequently, these multiplications were summed. Six biomarkers of inflammation were compiled in a summary score. Associations of the ADII (expressed per SD) with the summary score for inflammation and markers of glucose metabolism were investigated by using multiple linear regression models. Inflammation was considered a potential mediator in the analysis with markers of glucose metabolism. Results: A higher ADII was associated with a higher summary score for inflammation [b-adjusted = 0.04 per SD (95% CI: 0.01, 0.07 per SD)]. The ADII was also adversely associated with insulin resistance [homeostatic model assessment of insulin resistance (HOMA-IR): b-adjusted = 3.5% per SD (95% CI: 0.6%, 6.3% per SD)]. This association was attenuated after the inclusion of the summary score for inflammation [b-adjusted+inflammation = 2.2% (95% CI: 20.6%, 5.0%)]. The ADII was also adversely associated with fasting glucose and postload glucose but not with glycated hemoglobin. Conclusion: The significant mediating role of low-grade inflammation in the association between the ADII and HOMA-IR suggests that inflammation might be one of the pathways through which diet affects insulin resistance.
INTRODUCTION
Chronic low-grade inflammation is characterized by slightly elevated concentrations of circulating proinflammatory markers, including C-reactive protein (CRP) 5 , IL-6, and TNF-a. These markers have been associated with higher risk of type 2 diabetes in observational studies (1, 2) and can be induced by risk factors for type 2 diabetes, such as overweight (3) , physical inactivity (4), and diet (3) . Nutrients assumed to have an antiinflammatory effect, eg, fiber and moderate amounts of ethanol (3), may be associated with lower risk of diabetes (5, 6) . In contrast, nutrients assumed to have a proinflammatory effect, eg, SFAs and trans fatty acids (3) , may be associated with higher risk of diabetes (7) . Therefore, it could be hypothesized that certain nutrients may influence markers of glucose metabolism through their effect on chronic low-grade inflammation. However, nutrients are not consumed as individual components but with others present within a certain food product. Therefore, besides studying effects of nutrients on inflammation and markers of glucose metabolism, it is also important to study whether the overall diet is associated with markers of glucose metabolism through its effects on low-grade inflammation. A dietary index that reflects the quality of the diet, the alternative healthy eating index (AHEI), was associated with markers of low-grade inflammation and risk of type 2 diabetes (8, 9) . However, this index was not designed to reflect the inflammatory potential of the diet. To design an index that does reflect the inflammatory potential of the diet, Cavicchia et al (10) developed dietary inflammatory weights for a number of dietary components on the basis of a systematic review of available literature on diet and inflammation. For instance, ethanol had an antiinflammatory weight of 20.53, whereas SFA had a proinflammatory weight of 0.25. The weights can be used to obtain a dietary inflammatory index (DII) that reflects the inflammatory potential of the diet. To our knowledge, whether a DII is associated with any inflammation-related health outcomes, such as markers of glucose metabolism, has not been previously investigated.
Aims of this study were to investigate whether a DII is associated with 1) a summary score for low-grade inflammation and 2) markers of glucose metabolism in a Dutch population. In addition, we investigated whether the association between the DII and markers of glucose metabolism is mediated by chronic low-grade inflammation.
SUBJECTS AND METHODS

Study population
The study population consisted of participants from the following 2 Dutch cohorts: the Cohort study on Diabetes and Atherosclerosis Maastricht (CODAM) and the Hoorn study.
Briefly, the CODAM started in 1999 and is an ongoing cohort study. It was designed to investigate the effects of disturbed glucose metabolism, obesity, blood lipids concentrations, lifestyle factors, and genetic factors on cardiovascular disease and mortality (11) (12) (13) (14) (15) . The CODAM comprises 574 participants who were selected on the basis of elevated risk of type 2 diabetes and cardiovascular diseases from a large population-based cohort (n . 20,000) and had undergone a glucose metabolism screening test (n = 2715) (11, 16) .
Briefly, the Hoorn study started in 1989 with a sample of the general population of Hoorn, Netherlands (n = 2484) (17) . The Hoorn study is a population-based cohort study designed to investigate the effect of disturbed glucose metabolism on cardiovascular disease risk factors and complications (17) . In 2000-2001, 822 participants were examined again (18, 19) [ie, 648 surviving participants in the Hoorn study and an additional group of 174 participants with type 2 diabetes from the Hoorn screening study (20) ].
Both studies obtained written informed consent from all participants and were approved by the local Ethics Committees (CODAM: Medical Ethical Review Committee of the Maastricht University Medical Centre; Hoorn study: Ethical Review Committee of the VU University Medical Center Amsterdam).
Population for analysis
For the current investigation, data from both the baseline examination of the CODAM and the follow-up examination of the Hoorn study were used. We combined these studies because they had followed a similar data-collection research protocol and had been used as a combined cohort in previous investigations (21) (22) (23) . Of the 1397 participants with reliable measures of food intake obtained from a food-frequency questionnaire (FFQ) (518 subjects from the CODAM; 879 subjects from the Hoorn study), we excluded, in consecutive order, 138 participants with missing information on glucose metabolism status or inflammation markers, 105 participants with known diabetes, 22 participants with missing information on covariates used in the analysis, and 108 participants with a CRP concentration .10 mg/L. Participants with CRP concentrations .10 mg/L were excluded because these higher concentrations reflect acute rather than chronic inflammation (24) . Finally, the population for analysis comprised 1024 participants (420 subjects from the CODAM; 604 subjects from the Hoorn study).
Assessment of dietary intake
In both cohorts, dietary intake was assessed by using a selfadministered semiquantitative FFQ, which had been validated in a Dutch population (25) . Intakes of all food items were converted into intakes of energy and nutrients by using an extended version of the Dutch Food Composition table 2001 . The caffeine content of food items was not included in the Dutch Food Composition table. Therefore, the caffeine content was estimated to be 68 mg/ 100 mL coffee (26), 20 mg/100 mL tea (27) , and 8 mg/100 mL cola soft drink (27) .
Calculation of adapted dietary inflammatory index
Cavicchia et al (10) has developed literature-based dietary inflammatory weights that reflect the inflammatory potential of energy, 32 nutrients, 4 food products, 4 spices, and caffeine (Table 1) . In line with Cavicchia et al (10), we obtained a DII by multiplying the dietary inflammatory weights of the dietary components by the daily intake. Subsequently, these multiplications were summed. Details about the calculation of the DII are shown in Table 1 .
On the basis of a nutritional rationale, we also obtained an adapted dietary inflammatory index (ADII) by multiplying the dietary inflammatory weight of 26 nutrients, one food product, one spice, and caffeine by the standardized energy-adjusted intake. Subsequently, these multiplications were summed (Table 1) . We explain 1) why an energy-adjusted intake was used, 2) why the intake was standardized, and 3) why some dietary components were excluded. Other details are shown in Table 1 .
Energy-adjusted intake
We adjusted all dietary components for energy by using the residual method to reduce the between-person variation in dietary intake resulting from differences in physical activity, body size, and metabolic efficiency (29) . Therefore, the ADII was used as a measure of diet quality.
Standardized intake
To avoid that the variation in the ADII was solely driven by a few dietary components with a large range in intake, we standardized intake of all components. Standardization was done by subtracting the mean intake of the population from the individual intake and dividing the difference by the SD of the study population (z score) to equilibrate the intake of all nutrients to the same unit. Therefore, it was not necessary to divide intakes of vitamin A and b-carotene by the arbitrary, data-dependent 100 and multiply n23 and n26 fatty acids with the arbitrary, data-dependent 10 as Cavicchia et al (10) did (Table 1) . We also did not divide the overall ADII by 100 because division did not improve the interpretation of the results as it improved the interpretation of the previously published DII (10). Total DII for a participant
1 ADII, adapted dietary inflammatory index; DII, dietary inflammatory index; IW, inflammatory weight. 2 Dietary components with a positive IW were considered proinflammatory. Dietary components with a negative IW were considered antiinflammatory. 3 Energy was excluded in the ADII because all macronutrients were already included. Total fat was excluded in the ADII because all fatty acids were already included. Alcoholic beverages beer, wine, and liquor were excluded in the ADII because the intake of ethanol was already included. 4 trans Fatty acids were not included in the previously published DII because the intake of trans fatty acids could not be calculated in the study by Cavicchia et al (10) . 5 Dietary IW for ethanol was assumed to be zero when the intake of ethanol was .40 g/d because the intake of ethanol is not likely to be antiinflammatory when an intake is .40 g/d (29) . 6 Intake of tea was still included because the intake of epicatechin could not be calculated from our food-frequency questionnaire. 7 These dietary components were not taken into account in our DII and ADII calculations because intakes of these components could not be calculated from our food-frequency questionnaire.
8 Intake of n23 and n26 PUFAs were multiplied by 10 because intakes were low and expressed as grams per day. Intakes of vitamin A and b-carotene were divided by 100 to equilibrate the range of intake to other micronutrients according to Cavicchia et al (10) .
Exclusion components
We excluded several components when we calculated the ADII to avoid an overestimation of inflammatory effects of ethanol, fat, and energy. To reduce the impact of ethanol on the ADII, separate antiinflammatory effects of the alcoholic beverages beer, wine, and liquor were not taken into account. Antiinflammatory effects of these beverages are likely to be attributable to ethanol (3). Energy was excluded because it is likely that the inflammatory effect of energy is the sum of the inflammatory effects of all energy-providing macronutrients. Total fat was also excluded because it was assumed that the inflammatory effect of total fat is the sum of the inflammatory effects of all separate fatty acids.
Markers of glucose metabolism
Venous blood samples were drawn from all participants at the research center after an overnight fast (.10 h) to be able to measure, eg, the fasting glucose concentration, fasting insulin concentration, and glycated hemoglobin (Hb A 1c ). A 2-h postload glucose concentration was determined after a standard 75-g oral glucose tolerance test except in participants with established diabetes or a very high fasting plasma glucose concentration (CODAM: .10 mmol/L; Hoorn study: .8.0 mmol/L). Fasting and 2-h postload glucose concentrations were measured in plasma by using glucose hexokinase methods [CODAM: ABX Diagnostics Glucose HK125 (Horiba-ABX); Hoorn study: Roche Diagnostics]. Hb A 1c was analyzed by ion-exchange HPLC (CODAM and Hoorn study: Bio-rad). The insulin concentration was measured in plasma by a 2-site immunoradiometric assay by using paired monoclonal antibodies (CODAM and Hoorn study: Medgenix Diagnostics). Insulin resistance was estimated from fasting plasma glucose and plasma insulin concentrations by using the homeostasis model assessment calculator (HOMA2) (30) .
Markers of low-grade inflammation
In both cohorts, concentrations of 6 biomarkers of low-grade inflammation [ie, CRP, IL-6, IL-8, TNF-a, serum amyloid A (SAA), and soluble intercellular adhesion molecule-1 (sICAM)] were measured in plasma by using a multiarray detection system (MDS) on the basis of electro-chemiluminescence detection (SECTOR Imager 2400; MesoScaleDiscovery). All measurements were performed at the Research Laboratory, Department of Internal Medicine, Maastricht University Medical Centre (head: CGS). In the CODAM, CRP was also measured in serum by using a high-sensitivity immunoturbidimetry assay (Latex; Roche Diagnostics Netherlands BV), and IL-6, SAA, sICAM were also measured in EDTA plasma by using an ELISA (IL-6: R&D Systems; SAA and sICAM: Biosource; Invitrogen). These measurements were done at the Laboratory of Toxicology, Genetics and Pathology of the National Institute for Public Health and the Environment, Bilthoven, Netherlands. Values obtained by using the immunoturbidimetry assay or ELISA were calibrated on the values obtained by using the MDS in the CODAM. Subsequently, the calibrated and MDS values were averaged and used for CODAM participants in the current analysis. Intraassay CVs ranged from 0.6% to 6.4%, and interassay CVs ranged from 1.9% to 17.5%. More information about measurements has been shown elsewhere (12, 13, 31) .
Calculation summary score for low-grade inflammation A summary score for low-grade inflammation was calculated to cluster conceptually related markers of low-grade inflammation and improve statistical efficiency. To obtain this summary score, a z score for each marker of low-grade inflammation was calculated because the markers of low-grade inflammation were expressed on different scale units. Subsequently, these z scores were averaged to obtain a summary score for low-grade inflammation for each participant as follows:
Summary score ¼ ½z scoreðlog e CRPÞ þ z scoreðlog e IL À 6Þ þ z scoreðlog e IL À 8Þ þ z scoreðTNF À aÞ þ z scoreðlog e SAAÞ þ z scoreðsICAMÞO6 ð1Þ
This summary score for low-grade inflammation had been used in previous investigations (14, 31, 32) .
Covariates
In both cohorts, the participant completed a self-administered questionnaire that, among other things, included questions about age, sex, smoking behavior, family history of diabetes in firstdegree relatives, and use of medications (eg, antihypertensive, lipid-lowering, glucose-lowering medications). On the basis of the questions about smoking behavior, the participant was categorized as a never, former, or current smoker. Family history of diabetes was defined as a parent, a sibling, or both with diagnosed diabetes. Height was measured to the nearest centimeter, and weight was measured to the nearest 100 g by trained personnel. The participant was weighed in a standing position wearing light indoor cloths and no shoes. BMI (in kg/m 2 ) was calculated as weight divided by height squared. Waist circumference (cm) was obtained at levels halfway between the lateral lower rib margin and the spina iliaca anterior superior. Habitual physical activity was assessed by using a validated short physical activity questionnaire (short questionnaire to assess health-enhancing physical activity), which measured the duration and intensity of different activities (min/wk 3 intensity) (33) .
Statistical analysis
Summary statistics were used to describe population characteristics by tertiles of the ADII. To get more insight into the contribution of the individual dietary components to the total ADII, the contribution of the different dietary components to the variation between participants in the ADII was assessed by using forward linear regression. Before additional analyses, 7 skewed variables were log e transformed to improve their distribution toward normal (CRP, IL-6, IL-8, SAA, fasting plasma glucose, postload glucose, and HOMA-IR).
First, the association between the ADII and markers of lowgrade inflammation was investigated by using linear regression. Model 1 included, as the main independent variable, the ADII (expressed per SD) and the covariates age (y), sex, cohort (CODAM or Hoorn), smoking (never, former, or current), physical activity (min/wk 3 intensity, family history of diabetes (yes, no, or missing), use of lipid-lowering medication (yes or no), having hypertension (yes or no), and the intake of energy (kcal/d). Except for cohort, these covariates were included because of their association with inflammation and diabetes observed in the literature. In model 2, BMI was added to model 1 because we were also interested in the effect of the ADII on inflammation independent of BMI. Waist circumference was not included as an additional covariate because its inclusion did not change the conclusions, and waist circumference was missing for 8 participants. Effect-measure modification by sex was investigated by adding an interaction term between the ADII and sex to model 2 when the summary score for low-grade inflammation was studied as a dependent variable.
Second, to investigate whether this study also confirmed the well-known adverse associations between low-grade inflammation and markers of glucose metabolism, the association between the summary score for low-grade inflammation and the 4 markers of glucose metabolism was studied. Model 1 of the linear regression model included age (y), sex, cohort (CODAM or Hoorn), smoking (never, former, or current), physical activity (min/wk 3 intensity), family history of diabetes (yes, no, or missing), use of lipid-lowering medication (yes or no), and having hypertension (yes or no). Model 2 included BMI in addition to model 1.
Third, the association between the ADII and 4 markers of glucose metabolism (ie, fasting plasma glucose, postload glucose, HOMA-IR, and Hb A 1c ) was investigated by using linear regression. Model 1 included the ADII and other covariates as in model 1. To investigate the mediating role of low-grade inflammation, the summary score for low-grade inflammation was included in addition to covariates included in model 1 (model 1 + inflammation). To investigate whether the association of the ADII with markers of glucose metabolism was attributed to inflammation independent of BMI, the summary score for low-grade inflammation and BMI were simultaneously added to model 1. For this purpose, we also used the multiple-mediation analysis as described by Preacher and Hayes (34) . This mediation analysis provides an efficient way to quantify the independent mediating effects of low-grade inflammation and BMI ( Figure 1) .
All analyses were performed with the SAS statistical software package (version 9.2; SAS Institute Inc). P # 0.05 was considered statistically significant.
RESULTS
The mean (6SD) age of the population of analysis was 646 9 y, 59% of subjects were participants from the Hoorn study, 55% of subjects were men, 26% of subjects had a normal weight, 18% of subjects were current smokers, and 51% of subjects had normal glucose metabolism. The Hoorn study, compared with the CODAM, included participants with an older age (68 6 7 compared with 58 6 7 y, respectively), more women (49% compared with 37%, respectively), and fewer current smokers (16% compared with 20%), respectively. The mean BMI was comparable (27 6 4 in the Hoorn study; 28 6 4 in the CODAM).
ADII and its components
The ADII ranged from 212.0 to 15.7 (range: 27.7 units) ( Table 2) . Participants with a high ADII smoked more and were more often men than were participants with a low ADII ( Table  2) . Intakes of SFAs, MUFAs, and trans fatty acids were higher in participants with a high than low ADII. Intakes of protein, n23 PUFA, and n26 PUFA were lower in participants with a high than low ADII (see Supplemental Table 1 under "Supplemental data" in the online issue). The Spearman's correlation between the ADII and energy was low (r = 0.10, P = 0.02). The intake of magnesium explained most of the variation (34%) between participants in the ADII, followed by intakes of folate (25%), quercetin (16%), and n23 PUFA (7%) ( Table 3) . Regarding the DII, which ranged from 220.7 to 6.3 (range: 27.0 units) (see Supplemental Table 2 under "Supplemental data" in the online issue), the intake of tea explained most of the variation (55%) between participants in the DII, followed by intakes of SFA (17%), beer (13%), energy (6%), and wine (5%) ( Table 3 ).
ADII and low-grade inflammation
An increment of 1 SD in the ADII (ie, 2.88 units) was associated with a 0.04-unit (95% CI 0.01, 0.07-unit) higher summary score for low-grade inflammation in model 2 (P = 0.01) ( Table 4) . This association was mainly driven by 4 of 6 markers of inflammation (ie, CRP, IL-6, TNF-a, and sICAM). The original DII was not associated with the summary score for low-grade inflammation [model 2: b = 20.002 (95% CI: 20.03, 0.03)] ( Table 4 ). The association between the ADII and summary score for low-grade inflammation did not differ between men and women (P-interaction = 0.80). 
Low-grade inflammation and markers of glucose metabolism
The summary score for low-grade inflammation was associated with adverse concentrations of all markers of glucose metabolism ( Table 5 ). An increment of 1 unit in the summary score for low-grade inflammation was associated with, on average, a 4% (95% CI: 2%, 6%) higher fasting glucose concentration, a 9% (95% CI: 4%, 14%) higher postload glucose concentration, a 16% (95% CI: 11%, 22%) higher HOMA-IR, and a 0.21% (95% CI: 0.13%, 0.29%) higher Hb A 1c concentration (model 2).
ADII and markers of glucose metabolism
An increment of 1 SD in the ADII (ie, 2.88 units) was associated with, on average, a 0.9% (95% CI: 0.1%, 1.7%) higher fasting glucose concentration, a 2.3% (95% CI: 0.0%, 4.6%) higher postload glucose concentration, and a 3.5% (95% CI: 0.6%, 6.3%) higher HOMA-IR (Table 6, Table 6 ). When the summary score for low-grade inflammation and BMI were simultaneously added to model 1, the summary score for low-grade inflammation, but not BMI, explained a significant proportion of the association between the ADII and HOMA-IR (path a 1 3 path b 1 = 0.7% higher per SD through inflammation independent of BMI) and between ADII and postload glucose (path a 1 3 path b 1 = 0.5% higher per SD through inflammation independent of BMI) (Figure 1 , Table 6 ). ADII had no direct association (c#) with the 4 markers of glucose metabolism ( Figure 1 , Table 6 ).
Part of our population for analysis (n = 720; 70%) was retested with an oral glucose tolerance test, on average, 7.2 y after the baseline examination. Of the 592 participants without type 2 diabetes at baseline and with follow-up data, 99 subjects had type 2 diabetes at follow-up. The ADII was not associated with the incidence of type 2 diabetes [incidence proportion ratio model 1 = 1.00 (95% CI: 0.91, 1.09)].
DISCUSSION
The aims of this study were to investigate whether the inflammatory potential of the diet as assessed with the ADII is associated with 1) the summary score for low-grade inflammation and 2) markers of glucose metabolism. We observed an adverse association between the ADII and summary score for low-grade inflammation, which suggested that the inflammatory potential of the diet affects markers of inflammation. The adverse association between the ADII and HOMA-IR suggested that the inflammatory potential of the diet affects insulin resistance. This effect was supported by the mediating role of low-grade inflammation in this analysis on insulin resistance.
On the basis of our results, it is likely that the adaptations in the DII calculation improved the estimation of the inflammatory potential of the diet. First, the variation in the ADII was not solely driven by components with a large range in intake, in contrast to the previously published DII. The intake of tea explained most of the variation in the original DII in our study because the intake of tea ranged from 0 to 1500 mL/d. With the use of standardized intakes, the ADII was less dependent on the intake range of components in the study under investigation. Therefore, it is likely that the results from the ADII will be more comparable between populations. Second, the ADII also avoided an overestimation of the inflammatory effect of certain nutrients by excluding alcoholic beverages, total fat, and energy. Third, the ADII was associated with the summary score for low-grade inflammation, whereas the original DII was not associated with the summary score for low-grade inflammation in our study. The previously published DII was not associated with CRP on a continuous scale, although it was concluded that diet can affect low-grade inflammation on the basis of the observed adverse association between the DII and elevated CRP concentration (.3 mg/L) (10). Other diet-quality scores have been shown to be associated with chronic low-grade inflammation. The AHEI (8), the alternate Mediterranean diet index (MEDI) (8) , and the Mediterranean diet score (35) were inversely associated with CRP, IL-6, and sICAM. If examined closely, these scores have some similarities with the ADII. A low intake of cereal fiber and a high intake of trans fat are considered unhealthy in the AHEI, which is in line with the dietary inflammatory weights for total fiber (20.52) and trans fatty acids (0.26) in the ADII. Furthermore, the AHEI gives a preference to PUFAs and MEDI to MUFAs over SFAs. In the ADII, n23 PUFAs and MUFAs are considered antiinflammatory, whereas SFAs are considered pro-inflammatory. In addition, the intake of ethanol is considered healthy in the AHEI, MEDI, and Mediterranean diet score, which is in line with the dietary antiinflammatory weights for ethanol (20.53 ) in the ADII. Even though the purpose of these diet quality scores was not to assess the inflammatory potential of diet, these studies provided evidence that diet as a whole may play a role in chronic low-grade inflammation.
The summary score for low-grade inflammation explained a significant proportion of the association between the ADII and HOMA-IR, even independent of BMI. This result supported the hypothesis that low-grade inflammation mediates, at least in part, the association between diet and insulin resistance. As part of an inflammatory environment, a more proinflammatory diet could lead to an impaired action of insulin (7) . This hypothesis was not further confirmed by an association between ADII and incidence of type 2 diabetes in our cohorts. However, the analysis was 2 For the analysis, these markers of glucose metabolism were log e transformed to improve their distribution toward normal. Therefore, when the ADII was 1 SD (SD: 2.88) higher, these markers of glucose metabolism were, on average, b 3 100% higher or lower.
3 Model 1 was adjusted for age, sex, cohort, physical activity, smoking, family history of diabetes, use of lipidlowering medication, hypertension, and intake of energy. 4 When the ADII was 1 SD higher, the marker of glucose metabolism was b 3 100% higher or lower through the effect of the ADII on BMI.
5 Multiple mediation analysis described by Preacher and Hayes did not provide P values (34). 6 When the ADII was 1 SD higher, the marker of glucose metabolism was b 3 100% higher or lower through the effect of the ADII on inflammation.
limited because information about the exact time of diagnosis was not available, and the loss to follow-up was 30%. Therefore, the validity should be confirmed by results of prospective studies, preferably also with a larger number of incident cases before a clinical application of the ADII is considered.
There were a number of strengths of this study to consider. First, in addition to CRP, 5 other markers of inflammation were examined, which provided a more-thorough assessment of lowgrade inflammation. Second, a validated FFQ was used to assess intake. This FFQ has been shown to be appropriate for ranking participants for 10 of the nutrients included in the ADII (25) . Third, the ADII was strengthened by its theory and literaturebased instead of data-driven nature. However, despite the use of a systematic approach for constructing the literature-based dietary inflammatory weights, subjective decisions were made by Cavicchia et al (10) .
Besides these strengths, the study had limitations as well. First, our results were limited by the cross-sectional nature of our study, which did not allow conclusions to be made about causality. We tried to limit the possibility of reverse causation by excluding participants with known diabetes who may have changed their diet recently. Second, the external validity of our study might have been low because all participants were white, and the CODAM included participants with high risk of impaired glucose metabolism. However, the inclusion of a high-risk population increased the variation in markers of glucose metabolism. Third, intakes of some dietary components, which were included in the previously published DII, such as of ginger and saffron, could not be calculated from our FFQ (Table 1) . However, the variation in intakes of those specific dietary components was expected to be low in a mostly nonvegetarian Dutch population. Fourth, although extensive information about potential confounders was available, residual confounding might have remained because potential confounders could have been measured with error.
In conclusion, adverse associations between the inflammatory potential of the diet, as assessed with the ADII, with low-grade inflammation and HOMA-IR suggest that low-grade inflammation might be one of the pathways through which diet affects insulin resistance. More research is needed to verify whether the ADII is associated with low-grade inflammation in other populations and to investigate whether low-grade inflammation mediates the association between diet and the development of type 2 diabetes.
